Tag: PD-1 inhibitors

A retrospective study of 56 Chinese patients aged 60 and older found PD-1 inhibitor rechallenge after prior immunotherapy produced a ...

A meta-analysis of six randomized trials found that adding PD-1/PD-L1 inhibitors to chemotherapy was associated with longer progression-free and overall ...

A new case report describes a pembrolizumab-treated patient who developed primary hypothyroidism from immune thyroid destruction followed by rare isolated ...

A new study finds that an elevated platelet-to-lymphocyte ratio from a routine blood count strongly predicts poorer survival in relapsed ...

An analysis of nearly half a million clinical trials and real-world data from over 91,000 patients reveals that immune-related side ...

A new review synthesizes clinical trial evidence showing that combining radiotherapy with immune checkpoint inhibitors can dramatically boost response rates ...

In the ever-evolving landscape of cancer treatment, the advent of immunotherapy has ushered in a transformative era, particularly for patients ...

In the ever-evolving landscape of oncology, the search for effective therapeutic strategies against relapsed and refractory non-Hodgkin lymphoma (NHL) remains ...